Tag:
layoffs
Latest Headlines
Latest Headlines
End is near for Watson distribution center
The countdown to closing has begun on a Watson Pharmaceuticals ($WPI) distribution center in Ohio, as the company relocates operations to a smaller facility in Mississippi.
Pfizer making deep cuts at estrogen extraction plant
Pfizer ($PFE), which faces thousands of lawsuits over hormone replacement therapies, will cut about 40% of the workforce at a Canadian plant where one of them is made.
First wave of AstraZeneca's CNS R&D group gets the ax
AstraZeneca isn't wasting any time in pushing ahead with draconian cuts to its neuroscience work in its big R&D hub south of Stockholm.
INC Research to close another facility, laying off around 30
INC is facing another facility closure. Its clinical study unit in Morgantown, WV will be shut down, according to a story by The State Journal .
Merck Serono to cut 580 Swiss jobs, close Geneva HQ
Whatever its description, the German Merck's decision to shutter its Serono division's Geneva headquarters and cut up to 580 Swiss jobs is a big move to counter recent R&D setbacks.
Merck KGaA manufacturing dodges worst of reductions
The company is closing its Merck Serono headquarters in Geneva, Switzerland, and will eliminate 500 positions and transfer another 750 to locations around the world.
Merck KGaA chief swears off major deals amid pipeline woes
Company CEO Karl-Ludwig Kley informed investors today that his company would be focusing on its previously revealed cutbacks while avoiding large M&A deals through 2013.
As tax looms, device companies mull layoffs, cuts
A substantial number of medical device manufacturers are already looking at price hikes, cost cuts and layoffs as a way to live with a new industry tax slated to hit next year, according to a new KPMG survey.
Lilly CEO avoids Pfizer-like cuts, focuses on pipeline
John Lechleiter has held firm to his position that cutting expenses alone isn't a solution to the challenges at his company; he thinks that the way forward resides in the pipeline.
Novartis CEO explains how and why he cut jobs
Novartis CEO Joe Jimenez says he chose to cut jobs "from a position of strength," rather than wait until company performance forced his hand.
